The Challenges of Identifying Fibromyalgia in Adolescents

Table 2

Demographic and clinical characteristics (n = 20).

Age category, y, n (%)
10–14	8 (40%)
15–19	12 (60%)
Sex, n (%)
Male	1 (5%)
Female	19 (95%)
Race, n (%)
White	10 (50%)
Black	4 (20%)
Hispanic	3 (15%)
Asian	3 (15%)
Pain duration, mo	22 (16)
Pain in family history, n (%)	12 (60%)
Parental divorce or strain, n (%)	7 (35%)
Number of diagnostic tests	1.6 (0.6)
Full school attendance unchanged academic performance, n (%)	5 (25%)
WPI	7 (1.4)
SSS	12 (2.8)
Yunus criteria met, n (%)	17 (85%)
Treatment modalities	2.4 (0.99)
Functional restoration, mo	8.6 (3.4)

The data are presented as the mean (standard deviation) or n (%), as indicated. Type of testing each count as 1: labs, imaging, and dynamic testing. WPI: Widespread Pain Index; SSS: Symptom Severity Scale. Treatment modalities: medicationsphysical therapy, cognitive therapy, injections, and acupuncture. Duloxetine, pregabalin, gabapentin, milnacipran, low dose naltrexone, and birth control pill.